Washington: More vaccines are reportedly being prepared to combat the Covid virus. Consolation studies are now being published in connection with the Covid vaccine, the novavax. The study found that Novavax is 90 percent effective against Covid.
Researchers say that Novavax is effective for all types of Covid. The study was conducted in Mexico and the US. Another feature is that the novavax vaccine is easier to store and distribute than other vaccines available in different parts of the world.
The company will soon seek permission for emergency use in the US and Europe. The company aims to produce 100 million vaccine doses by the end of September, according to reports. It is estimated that the production of vaccines can be accelerated globally if novavax is approved. Novavax will be manufactured by the Serum Institute in India. It is hoped that this will address vaccine tolerance in India.
